EMA starts review of meningioma risk with nomegestrol- and chlormadinone-containing medicines

View source ↗

Summary

EMA initiates a review of the potential risk of meningioma with medicines containing nomegestrol or chlormadinone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• chlormadinone-containing medicines (chlormadinone)
• nomegestrol-containing medicines (nomegestrol)